Home›Stock Screener›Sandu Pharmaceuticals

Sandu Pharmaceuticals Share Price Today | Stock Price & Sandu Pharmaceuticals Share Screener

SANDUPHQ Pharmaceuticals & Biotechnology
Live Share Price BSE
₹36.80
▼ -0.44 (-1.18%)
2026-11-19 00:00:00

As of November 19, 2026, the live Sandu Pharmaceuticals share price (BSE: SANDUPHQ) is ₹36.80, down 1.18% from the previous close, with shares trading between ₹36.80 and ₹37.20 in today's trading session, and a 52-week range of ₹30.52–₹46.12. Track SANDUPHQ company valuation to gauge the company's total market size. Use the Sandu Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sandu Pharmaceuticals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Sandu Pharmaceuticals Market Cap ₹36.20 Cr.
SANDUPHQ P/E Ratio (TTM) 20.70
Sandu Pharmaceuticals P/B Ratio 1.04
EPS (TTM) ₹1.60
Dividend Yield 2.64%
Debt to Equity -
SANDUPHQ 52 Week High ₹46.12
Sandu Pharmaceuticals 52 Week Low ₹30.52
Operating Margin 3.00%
Profit Margin -
SANDUPHQ Revenue (TTM) ₹14.00
EBITDA ₹1.00
Net Income -
Total Assets ₹56.00
Total Equity ₹42.00

Sandu Pharmaceuticals Share Price Chart

Track the current stock price of Sandu Pharmaceuticals with an interactive chart. Analyse SANDUPHQ share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sandu Pharmaceuticals stock quote in one place.

The quote of ₹36.80 sits between the 52-week low of ₹30.52 and the 52-week high of ₹46.12, and the latest session moved -1.18% from the previous close.

Sandu Pharmaceuticals Company Profile - Fundamental Screener

Screen Sandu Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANDUPHQ shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE751D01014.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE751D01014

Sandu Pharmaceuticals Balance Sheet Screener

Screen SANDUPHQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹56, up from ₹52 in 2024.

Latest statistics put total assets at ₹56 and shareholder funds at ₹42.

Item 2025 2024 2023

Assets

Total Assets 56 52 54
Current Assets 0 0 0
Fixed Assets 18 18 17

Liabilities

Total Liabilities 0 0 0
Current Liabilities 2 1 1
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 42 41 39
Share Capital 10 10 10
Reserves & Surplus 32 31 30

Sandu Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Screen Sandu Pharmaceuticals income statement and profit fundamentals. Analyze SANDUPHQ quarterly results. Sandu Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Mar, revenue was ₹14 and net profit was ₹0, equal to earnings per unit of ₹0.34, at an operating margin of 3%.

In that period expenses were ₹14, interest cost ₹0 and tax ₹0. The next period listed, 2024-Mar, shows revenue of ₹16 and net profit of ₹1.

Item 2025-Mar 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept 2022-Dec 2021-Jun 2021-Sept

Revenue and Expenses

Revenue 14 16 17 18 18 15 18 17 18 12 16 17 17 17 18
Expenses 14 15 17 17 17 15 17 16 17 11 16 16 16 17 17

Operating Costs and Margins

EBITDA 1 1 0 1 1 1 0 1 1 1 0 1 1 1 1
Operating Profit % 3.00% 4.00% 2.00% 5.00% 5.00% 3.00% 2.00% 5.00% 3.00% 5.00% 2.00% 5.00% 5.00% 4.00% 5.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 1 0 1 1 0 0 1 0 0 0 1 1 1 1
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 1 0 1 1 0 0 1 0 0 0 1 1 0 0
EPS 0.34 0.62 0.17 1.95 0.57 0.26 0.11 0.57 0.21 0.34 0.19 0.64 0.51 0.53 0.57

Sandu Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen SANDUPHQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹1.

Over the same period, investing activities provided ₹0 and financing activities used ₹1.

Item 2025-March 2024-March 2023-March

Cash from Operations and Investing

Operating Activities 1 1 0
Investing Activities 0 -1 1

Financing and Net Cash

Financing Activities -1 -1 1
Net Cash Flow 0 -1 1

Sandu Pharmaceuticals Shareholding Pattern Screener

See Sandu Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Sandu Pharmaceuticals promoter holding and ownership changes for SANDUPHQ on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 37.79%, foreign institutions 0.00%, domestic institutions 0.01% and the public 36.98%, spread across 10,298 shareholders.

The shareholder count was 10,298 in 2026-Mar, compared with 10,268 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 37.79% 37.79% 37.79% 42.90% 42.90% 42.90% 37.79% 42.90%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.01% 0.01% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 36.98% 37.02% 37.08% 35.90% 36.57% 36.77% 37.01% 44.16%
Other Holding 25.23% 25.19% 25.12% 21.20% 20.53% 20.32% 25.19% 12.93%
Shareholder Count 10,298 10,268 10,441 10,287 10,226 10,284 10,284 10,001

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sandu Pharmaceuticals. Sandu Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.80 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.80 and ₹0.80 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.80 2.62%
2024-March ₹0.80 1.63%
2023-March ₹0.00 0.00%
2022-March ₹0.75 1.43%
2021-March ₹0.50 0.71%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Sandu Pharmaceuticals Stock Index Membership - Nifty & Sensex

See which indices include Sandu Pharmaceuticals stock. Check SANDUPHQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Sandu Pharmaceuticals is not part of any tracked indices.
Only major market indices are tracked in our system.

Sandu Pharmaceuticals Market Events Screener - Corporate Actions

Get Sandu Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sandu Pharmaceuticals stock events that may affect SANDUPHQ share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Annual General Meeting dated September 11, 2026 and Dividend dated September 4, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA 4.37%
2026-09-11 2026-09-11 Annual General Meeting NA -4.87%
2026-09-04 2026-09-04 Dividend ₹ 1.00 /share -9.00%
2026-08-11 2026-08-11 Quarterly Result Announcement NA 1.95%
2026-05-05 2026-05-05 Quarterly Result Announcement NA -1.85%
2026-02-06 2026-02-06 Quarterly Result Announcement NA 2.05%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -2.51%
2025-09-30 2025-09-30 Annual General Meeting NA -3.84%
2025-09-18 2025-09-18 Dividend ₹ 0.80 /share -12.97%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 0.76%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 4.41%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -3.54%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 2.33%
2024-09-30 2024-09-30 Annual General Meeting NA 3.42%
2024-09-19 2024-09-20 Dividend ₹ 0.80 /share 4.55%

Sandu Pharmaceuticals Competitors Screener - Peer Stocks Comparison

Screen SANDUPHQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.20 61,674 12.69% 11,565 63.60
Divis Laboratories 303,749 90.40 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,632 85.50 13,886 20.34% 2,138 47.27
Laurus Labs 130,972 97.10 6,868 22.01% 890 69.60
Zydus Life Science 118,693 28.00 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,186 42.00 35,059 3.90% 4,158 70.24
Cipla 112,438 39.90 29,045 2.24% 3,870 54.92
Mankind Pharma 109,044 48.10 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,903 26.00 34,145 5.56% 3,503 66.06
Lupin 90,557 17.60 29,039 26.75% 5,356 44.92

Sandu Pharmaceuticals Company Announcements - News & Reports Screener

Screen SANDUPHQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 19, 2026.

The next most recent announcements are dated November 19, 2026 and November 19, 2026.

Date Update Actions
2026-11-19 Statement Of Deviation And Variation Of Funds For Q Ended 30Th September 2026 -
2026-11-19 Financial Results For Q And Half Year Ended 30Th Sept 2026 -
2026-11-19 Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th November 2026 -
2026-11-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-04 Board Meeting Intimation for Approval Of Unaudited Financials For Quarter And Half Year Ended 30Th September 2026 -
2026-10-09 Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta. -
2026-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-30 Intimation To The Holders Of Physical Securities To Furnish PAN And KYC Details -
2026-09-22 Closure of Trading Window -
2026-09-12 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-09-12 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-09-12 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-11 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-20 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-19 Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Registered With The Company/RTA -
2026-08-19 Reg. 34 (1) Annual Report. -
2026-08-19 Annual General Meeting To Be Held On 11Th September 2026 At 04:30 Pm Through Video Conferencing (VC)/ Other Audio Visual Means (QAVM) -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹36.80, within a 52-week range of ₹30.52 to ₹46.12. The P/E ratio is 20.70 and the P/B ratio is 1.04, with earnings per unit of ₹1.60. Market capitalisation stands at ₹36.20 Cr and the dividend yield is 2.64%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 20, 2026. This page covers 3 balance sheet periods, 15 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.